Levi & Korsinsky commenced an investigation of the Board of Directors of
Forest Laboratories, Inc. ("Forest" or "the Company") (NYSE: FRX) for
possible breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to Actavis plc (NYSE: ACT).
Click here to learn more: http://zlk.9nl.com/forest-laboratories-frx,
or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Forest shaeholders will receive
$26.04 in cash and 0.3306 of an Actavis share for each share of Forest
stock they own, representing a value of approximately $89.48 in cash.
The investigation concerns whether the Forest Board breached their
fiduciary duties to stockholders by failing to adequately shop the
Company before agreeing to enter into this transaction, and whether
Actavis is underpaying for Forest shares.
If you own Forest common stock and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email at email@example.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/forest-laboratories-frx.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please feel
free to contact any of the attorneys listed below. Attorney advertising.
Prior results do not guarantee similar outcomes.
[ Back To NFVZone's Homepage ]